Anti-Proliferative Effects of Compound a and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells
BACKGROUND: Cholangiocarcinoma (CCA) is a fatal cancer with high resistance to anticancer drugs. The development of new drugs or compounds to be used alone or in combination with currently available chemotherapeutic agents to improve the treatment of CCA is needed. Compound A (CpdA), which is a sma...
Saved in:
Main Authors: | Mutita Junking, Thidarath Rattanaburee, Aussara Panya, Irina Budunova, Guy Haegeman, Pa Thai Yenchitsomanus |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85092062803&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70186 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Anti-proliferative effects of compound a and its effect in combination with Cisplatin in Cholangiocarcinoma Cells
by: Mutita Junking, et al.
Published: (2020) -
Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A
by: Thidarath Rattanaburee, et al.
Published: (2018) -
Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells
by: Chutamas Thepmalee, et al.
Published: (2018) -
Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells
by: Chutamas Thepmalee, et al.
Published: (2018) -
Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells
by: Chutamas Thepmalee, et al.
Published: (2019)